SCHEMBL28040574

SCHEMBL28040574

NC(=O)Cc1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
HSD17B10 Q99714 1/20 0.53
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAPT P10636 2/20 0.48
CYP1A2 P05177 1/20 0.46
VCAM1 P19320 1/20 0.45
HTT P42858 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
RORC P51449 1/20 0.44
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
FLT1 P17948 1/20 0.44
FLT4 P35916 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7126585 0.89 HSD17B10 (0.55) KMT2AHSD17B10LMNAALDH1A1KDM4E
SCHEMBL30100426 0.87 KMT2A (0.59) KMT2AHSD17B10LMNAALDH1A1MEN1
SCHEMBL3266897 0.85 CYP1A2 (0.64) KMT2AHSD17B10LMNAALDH1A1KDM4E
SCHEMBL2528182 0.85 CYP1A2 (0.64) KMT2AHSD17B10LMNAALDH1A1KDM4E
SCHEMBL28747080 0.84 KMT2A (0.53) KMT2AHSD17B10LMNAALDH1A1KDM4E
Water SCHEMBL6057599 0.84 CYP1A2 (0.62) KMT2AHSD17B10LMNAALDH1A1KDM4E
SCHEMBL8280283 0.84 HSD17B10 (0.53) KMT2AHSD17B10LMNAALDH1A1KDM4E
SCHEMBL27462575 0.84 HSD17B10 (0.53) KMT2AHSD17B10LMNAALDH1A1KDM4E
SCHEMBL4002644 0.82 GAA (0.54) KMT2AALDH1A1MEN1SMN1; SMN2MAPT
SCHEMBL3723235 0.81 ALDH1A1 (0.50) KMT2ALMNAALDH1A1MEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105228982-A 3-acetylamino-1- (phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino) benzene derivatives for the treatment of hyperproliferative disorders Bayer Pharma AG 2016-01-06 CN disclosed